The results are laughable honestly
lets remember 12 months ago we got roughly 47% PcP from 2017 - 2018 so saying growth in January is not an excuse .
we didn’t have/ very early days in
3D sales
India
4c added to ADAPT
GPO contract
Canada 3D approval and Vascucel
continued growth
3D in UAE
Cardiocel in Vietnam
and also we were told sales were low last year due to sales staff getting trained
Ann: Appendix 4C - quarterly, page-57
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
-0.300(1.73%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| $17.00 | $17.44 | $16.95 | $184.6K | 10.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 191 | $17.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.50 | 500 | 1 |
View Market Depth
| Last trade - 15.59pm 19/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |